je.st
news
Compugen Discloses New Results For Novel Target Candidate For Cancer Immunotherapy
2014-10-01 14:07:35| drugdiscoveryonline Home Page
Compugen Ltd. recently disclosed results from recent studies further confirming CGEN-15049 as a promising target candidate for cancer immunotherapy. These recent studies evaluated the function of this Compugen-discovered immune checkpoint candidate on immune cells derived from the tumor environment of melanoma patients
Tags: results
target
cancer
candidate
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||